AKESO ANNOUNCED COLLABORATION WITH CHIPSCREEN BIOSCIENCES TO INITIATED A CLINICAL TRIAL OF PD-1/CTLA-4 BI-SPECIFIC ANTIBODY IN COMBINATION WITH CHIAURANIB FOR PD-(L)1 PRETREATED ES-SCLC ...Middle East

PR Newswire - News

Read More Details
Finally We wish PressBee provided you with enough information of ( AKESO ANNOUNCED COLLABORATION WITH CHIPSCREEN BIOSCIENCES TO INITIATED A CLINICAL TRIAL OF PD-1/CTLA-4 BI-SPECIFIC ANTIBODY IN COMBINATION WITH CHIAURANIB FOR PD-(L)1 PRETREATED ES-SCLC )

Apple Storegoogle play

Also on site :

Most viewed in News